Concentrix revamps credit facilities, secures $2.6 billion

Published 11/04/2025, 21:12
Concentrix revamps credit facilities, secures $2.6 billion

Concentrix Corporation (NASDAQ:CNXC), a $3.1 billion market cap company with annual revenues of $9.6 billion, has entered into a significant amendment and restatement agreement, reshaping its credit facilities to secure a total of $2.6 billion in financing, according to a recent SEC filing. The transaction took place today, with Bank of America now serving as the administrative agent, taking over from JPMorgan Chase (NYSE:JPM) Bank. According to InvestingPro analysis, the company maintains a strong financial health score of "GOOD," with liquid assets exceeding short-term obligations.

The restated credit agreement consists of various components: a new $750 million term loan, a $250 million three-year delayed draw term loan, a $500 million five-year delayed draw term loan, and a $1.1 billion revolving credit facility. Additionally, the agreement allows for a potential increase in borrowing capacity of up to $500 million under certain conditions. With a current ratio of 1.65, the company demonstrates solid liquidity management despite carrying total debt of $5.7 billion.

The new term loan’s proceeds will be used to repay existing debt and for general corporate purposes. The delayed draw term loans, available until September 30, 2025, are earmarked to settle a €700 million promissory note related to Concentrix’s combination with Webhelp in September 2023 and for other corporate needs.

The maturity dates for the new term loan and the three-year delayed draw term loan are set for September 30, 2028, while the five-year delayed draw term loan and the revolving credit facility will mature on April 11, 2030. The existing term loan, now continued under the new agreement, will retain its original maturity date of December 27, 2026.

Interest rates for the loans under the restated agreement are tied to the SOFR rate plus a margin that varies depending on Concentrix’s credit ratings. The agreement also imposes certain financial covenants, including maintaining specific leverage and interest coverage ratios.

Concurrent with the amendment agreement, Concentrix also amended its accounts receivable securitization facility to align with the new credit agreement terms. This information is based on a press release statement.

In other recent news, Concentrix Corp reported its first-quarter 2025 earnings, exceeding expectations with an adjusted earnings per share (EPS) of $2.79, surpassing the forecasted $2.61. Revenue for the quarter was in line with projections at $2.37 billion, reflecting a 1.3% year-over-year growth on a constant currency basis. The company demonstrated strong performance, attributed to its strategic investments in AI technologies and integration of WebHelp synergies. Analysts noted a positive outlook for Concentrix, with revenue guidance for fiscal year 2025 set between $9.49 billion and $9.635 billion. Concentrix also expects non-GAAP EPS to range from $11.18 to $11.77, indicating continued confidence in their financial trajectory. The firm plans to maintain a conservative approach to its guidance, as emphasized by CFO Andre Valentine. Additionally, Concentrix’s strategic focus on AI deployment and operational synergies was highlighted as a key driver of its robust results.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.